Xingfa Chem(SH:600141)2021-04-28 16:00Financial Performance - Net profit attributable to shareholders of the listed company was CNY 354,646,397.86, representing a significant increase of 1,363.57% year-on-year[4] - Operating revenue for the period was CNY 4,466,662,659.22, reflecting a growth of 14.33% compared to the same period last year[4] - Basic earnings per share were CNY 0.32, a substantial increase of 1,500% compared to CNY 0.02 in the same period last year[4] - The company reported a significant increase in accounts receivable, which rose to ¥248,966,030.46, up 42.55% from ¥174,505,162.13[17] - Comprehensive income for Q1 2021 totaled ¥382,927,259.83, compared to ¥7,450,134.77 in Q1 2020, indicating robust overall performance[20] Cash Flow - Net cash flow from operating activities amounted to CNY 444,710,531.80, a remarkable increase of 257.16% year-on-year[4] - Cash inflows from operating activities totaled CNY 3.69 billion, up from CNY 2.83 billion year-over-year, reflecting a growth of approximately 30.7%[23] - The net cash flow from operating activities was CNY 444.71 million, compared to CNY 124.51 million in the first quarter of 2020, representing a year-over-year increase of 256.5%[24] - The net cash flow from financing activities was negative at CNY 502.46 million, compared to a positive CNY 640.21 million in the first quarter of 2020, indicating a shift in financing strategy[24] - Cash outflows from investing activities amounted to CNY 254.25 million, a decrease from CNY 531.43 million in the previous year, showing a reduction of approximately 52.2%[24] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 29,489,811,552.57, a slight increase of 0.10% compared to the end of the previous year[4] - Total liabilities amounted to ¥18,298,773,146.70, a decrease of 1.96% from ¥18,664,386,176.91 in the previous period[16] - Owner's equity totaled ¥11,191,038,405.87, an increase of 3.66% from ¥10,795,357,496.13 in the previous period[16] - The company’s total current liabilities decreased to approximately ¥11.85 billion from ¥12.97 billion year-over-year[15] - Long-term borrowings increased to approximately ¥4.32 billion from ¥3.58 billion at the end of 2020[15] Research and Development - Research and development expenses rose by 139.71% to ¥108,736,130.72 from ¥45,362,477.41 year-on-year, indicating a significant increase in investment in R&D[11] - Research and development expenses rose to ¥108,736,130.72 in Q1 2021, up 139.9% from ¥45,362,477.41 in Q1 2020[19] Shareholder Information - The total number of shareholders at the end of the reporting period was 45,544[6] - The top shareholder, Yichang Xingfa Group Co., Ltd., held 240,830,765 shares, accounting for 21.51% of the total shares[6] - The company’s controlling shareholder pledged 10 million shares, with a total of 37 million shares pledged, accounting for 15.36% of its holdings[12] Government Support - The company received government subsidies amounting to CNY 15,909,206.96 during the reporting period[5] - The company received the "High-tech Enterprise Certificate," allowing it to enjoy a 15% corporate income tax rate from 2021 to 2023[12] Other Financial Metrics - The weighted average return on equity increased to 3.68%, up by 3.38 percentage points from the previous year[4] - The company’s management expenses increased by 51.22% to ¥60,406,190.33 from ¥39,946,605.13, influenced by reduced expenses in the previous year due to the pandemic[11] - The company reported investment income surged by 91.11% to ¥30,177,514.57 from ¥15,790,768.19, driven by increased profits from associated companies[11]